2-氟-5-甲基磺酰苯胺 | 395090-68-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯
• 中文名称: 2-氟-5-甲基磺酰苯胺
• 英文名称: beta,beta-dimethyl-1-pyrrolepropanoic acid
• 英文别名: 3-Methyl-3-(1H-pyrrol-1-yl)butanoic acid；3-methyl-3-pyrrol-1-ylbutanoic acid
• CAS: 395090-68-3
• 化学式: C₉H₁₃NO₂
• 分子量: 167.208
• InChiKey: FVUKITSPMXBMLI-UHFFFAOYSA-N

物化性质

• 熔点：
  70-72°C

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.44
• 拓扑面积：
  42.2
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  2-氟-5-甲基磺酰苯胺 、 2-Cyclohexylmethyl-5-methyl-2H-pyrazol-3-ylamine 在 chloro-N,N,N',N'-bis(tetramethylene)formamidinium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.08h， 生成
  参考文献：
  名称：

  Discovery and Characterization of 1H-Pyrazol-5-yl-2-phenylacetamides as Novel, Non-Urea-Containing GIRK1/2 Potassium Channel Activators

  摘要：

  The G protein-gated inwardly-rectifying potassium channels (GIRK, KO) are a family of inward-rectifying potassium channels, and there is significant evidence supporting the roles of GIRKs in a number of physiological processes and as potential targets for numerous indications. Previously reported urea containing molecules as GIRK1/2 preferring activators have had significant pharmacokinetic (PK) liabilities. Here we report a novel series of 1H-pyrazolo-5yl-2-phenylacetamides in an effort to improve upon the PK properties. This series of compounds display nanomolar potency as GIRK1/2 activators with improved brain distribution (rodent K-p > 0.6).

  DOI：

  10.1021/acschemneuro.7b00217

文献信息

• Naphthalene Derivatives as Modulators of the Glucocorticoid Receptor
  申请人：Rafferty Stephen William

  公开号：US20090093464A1

  公开（公告）日：2009-04-09

  The present invention relates to naphthalene derivatives of formula (I) that are modulators of the glucocorticoid receptor, and to processes for the preparation and use of the same.

  本发明涉及式（I）的萘衍生物，其为糖皮质激素受体的调节剂，以及其制备和使用的方法。
• Composition
  申请人：Innospec Deutschland GmbH

  公开号：EP2287277A1

  公开（公告）日：2011-02-23

  The present invention provides an additive composition for fuel, a fuel composition, and methods for and uses of such compositions. In particular, the present invention relates to compositions which may be used to reduce the soot content and the ash content of an exhaust of a combustion system for fuel. In particular, the compositions comprise: (i) a metal compound selected from an iron compound, a manganese compound, a calcium compound, a cerium compound and mixtures thereof; and (ii) an organic compound selected from a bicyclic monoterpene, substituted bicyclic monoterpene, adamantane, propylene carbonate and mixtures thereof.

  本发明提供了一种燃料添加剂组合物、一种燃料组合物以及这种组合物的方法和用途。特别是，本发明涉及可用于降低燃料燃烧系统排气中烟尘含量和灰分含量的组合物。特别是，这些组合物包括 (i) 选自铁化合物、锰化合物、钙化合物、铈化合物及其混合物的金属化合物；以及 (ii) 有机化合物，选自双环单萜、取代双环单萜、金刚烷、碳酸丙烯酯及其混合物。
• [9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2,1-a]isoquinolin-2-yl]methanol and compounds, compositions and methods relating thereto
  申请人：Neurocrine Biosciences, Inc.

  公开号：US11053242B2

  公开（公告）日：2021-07-06

  Compounds having a structure of formula (I), including stereoisomers and pharmaceutically acceptable salts and solvates thereof: wherein R1 is as defined herein. Such compounds are inhibitors of the vesicular monoamine transporter 2 (VMAT2) and have utility for treating, for example, hyperkinetic disorders. Also disclosed are compositions containing these compounds in combination with a pharmaceutically acceptable carrier or diluent, as well as methods relating to the use in a subject in need thereof.

  具有式 (I) 结构的化合物，包括立体异构体及其药学上可接受的盐和溶液： 其中 R1 如本文所定义。这类化合物是囊泡单胺转运体 2（VMAT2）的抑制剂，可用于治疗过度运动障碍等疾病。还公开了含有这些化合物的组合物与药学上可接受的载体或稀释剂的组合物，以及有关在有需要的受试者中使用的方法。
• FUEL ADDITIVES
  申请人：THE ASSOCIATED OCTEL COMPANY LIMITED

  公开号：EP1047755A1

  公开（公告）日：2000-11-02
• FUEL ADDITIVE FOR THE PREVENTION OF VALVE SEAT RECESSION
  申请人：THE ASSOCIATED OCTEL COMPANY LIMITED

  公开号：EP1230327B1

  公开（公告）日：2006-06-07